Equities

Butterfly Network Inc

Butterfly Network Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.975
  • Today's Change0.008 / 0.83%
  • Shares traded1.13m
  • 1 Year change-54.01%
  • Beta2.1575
Data delayed at least 15 minutes, as of May 10 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Butterfly Network, Inc. is a digital health company. The Company is focused on transforming care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. It has two portable ultrasound devices on the market: second-generation Butterfly iQ+ and third-generation Butterfly iQ3. Butterfly iQ+/iQ3 are both powered by its Ultrasound-on-Chip technology, allowing them to power whole-body imaging on a single handheld probe using digital semiconductor technology. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Within the Butterfly application, users can utilize up to six imaging modes, including B-Mode, Color Doppler, M-Mode, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging.

  • Revenue in USD (TTM)68.08m
  • Net income in USD-121.92m
  • Incorporated2020
  • Employees225.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CVRx Inc42.09m-52.01m157.86m200.00--2.38--3.75-2.48-2.482.013.070.36780.67815.64210,430.00-45.45---48.95--84.45---123.58--10.87-21.110.3064--74.89--0.5528------
InfuSystem Holdings Inc125.79m872.00k160.76m499.00190.763.0611.971.280.03960.03965.862.471.2411.176.85252,074.100.86214.601.015.6950.1756.430.69334.071.541.880.35750.0014.4413.384,744.44--6.01--
Semler Scientific Inc65.88m21.69m162.23m92.008.262.047.262.462.782.788.4511.260.85515.138.51716,097.8028.1438.8331.1444.4189.4390.2232.9232.5812.11--0.00--20.2825.9843.6932.64-0.3821--
Clearpoint Neuro Inc23.96m-22.09m167.54m107.00--7.11--6.99-0.8979-0.89790.97360.85890.48811.208.15223,878.50-45.01-34.75-52.63-39.6756.8364.75-92.21-76.913.80--0.3197--16.5626.64-34.40--75.30--
Accuray Inc430.55m-21.49m167.60m1.02k--4.08--0.3893-0.2197-0.21974.420.41430.91781.865.72420,462.90-4.58-1.45-7.84-2.4833.0637.86-4.99-1.620.778-0.38570.8086--4.122.03-73.56--13.92--
Outset Medical Inc130.38m-172.80m169.07m480.00--1.34--1.30-3.49-3.492.642.440.36522.014.27271,616.70-48.41-41.40-56.97-47.2922.245.71-132.54-159.054.37-67.800.5143--13.00130.43-6.04--14.27--
Orchestra Biomed Holdings Inc2.76m-49.12m177.14m56.00--2.60--64.18-1.49-1.490.08321.900.02890.881528.3149,285.71-51.49---61.01--93.26---1,779.71--7.94--0.00---21.88---37.91------
Stereotaxis Inc26.77m-22.06m179.86m122.00--10.85--6.72-0.2737-0.27370.33180.27080.56171.466.01219,434.40-43.46-25.02-61.11-34.1255.5167.57-77.37-41.901.88--0.00---4.89-1.82-12.33--6.63--
Inogen Inc315.66m-102.45m204.62m834.00--0.9897--0.6482-4.42-4.4213.628.780.86346.766.01378,489.20-28.02-8.23-34.53-9.5340.1444.54-32.46-10.312.56--0.00---16.32-2.49-22.30--26.34--
Butterfly Network Inc68.08m-121.92m205.44m225.00--1.01--3.02-0.5893-0.58930.3290.96850.20450.69544.97302,577.80-36.61---42.07--26.50---179.08--3.34--0.00---10.21--20.76------
Akoya Biosciences Inc96.63m-63.32m221.05m330.00--4.09--2.29-1.48-1.482.181.090.54232.497.23292,827.30-35.53---44.59--58.27---65.53--2.94-10.940.5882--29.09--10.36------
Neuropace Inc65.42m-32.96m228.90m171.00--10.74--3.50-1.28-1.282.530.74230.5901.656.61382,578.90-29.72---33.88--73.56---50.38--5.02-4.970.7339--43.72--30.00------
AngioDynamics, Inc.324.01m-192.37m245.13m815.00--1.13--0.7566-4.78-4.788.105.410.74682.666.46397,555.80-44.34-9.12-54.02-10.1750.1754.23-59.37-19.481.62--0.00--7.135.30-97.54--3.55--
Utah Medical Products, Inc.50.22m16.64m249.26m169.0015.181.9610.864.964.574.5713.8135.350.38732.1911.25297,183.4012.8312.6913.3813.1959.8161.5733.1230.5120.53--0.0037.05-3.933.640.98341.659.711.86
Senseonics Holdings Inc22.39m-60.39m255.43m132.00--7.13--11.41-0.1023-0.10230.03870.13850.14182.406.41169,621.20-38.24-73.65-45.21-106.9713.81-40.41-269.73-649.867.03--0.3593--36.623.43-142.49---18.76--
Data as of May 10 2024. Currency figures normalised to Butterfly Network Inc's reporting currency: US Dollar USD

Institutional shareholders

26.03%Per cent of shares held by top holders
HolderShares% Held
ARK Investment Management LLCas of 31 Mar 202411.29m6.22%
BlackRock Fund Advisorsas of 31 Dec 20239.54m5.25%
Glenview Capital Management LLCas of 31 Dec 20238.03m4.42%
The Vanguard Group, Inc.as of 31 Dec 20237.54m4.15%
Geode Capital Management LLCas of 31 Dec 20233.16m1.74%
SSgA Funds Management, Inc.as of 31 Dec 20233.08m1.69%
Cetera Investment Advisers LLCas of 31 Dec 20231.26m0.69%
Charles Schwab Investment Management, Inc.as of 31 Dec 20231.21m0.67%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 20231.19m0.65%
Bill & Melinda Gates Foundation Trust (Investment Management)as of 31 Dec 20231.01m0.56%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.